Evidence map›Paper›PMID 37434303›Full record

ReviewThe New phytologist2023

Tale of cAMP as a second messenger in auxin signaling and beyond.

Linlin Qi, Jiří Friml

Abstract readReview
In one paragraph

Review in The New phytologist, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Slow and rapid auxin responses in Arabidopsis.Journal of experimental botany · 2024
    Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Linlin QiInstitute of Science and Technology Austria (ISTA), Klosterneuburg, 3400, Austria.ORCID 0000-0001-5187-8401
Jiří FrimlInstitute of Science and Technology Austria (ISTA), Klosterneuburg, 3400, Austria.ORCID 0000-0002-8302-7596

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 3',5'-cyclic adenosine monophosphate (cAMP) is a versatile second messenger in many mammalian signaling pathways. However, its role in plants remains not well-recognized. Recent discovery of adenylate cyclase (AC) activity for transport inhibitor response 1/auxin-signaling F-box proteins (TIR1/AFB) auxin receptors and the demonstration of its importance for canonical auxin signaling put plant cAMP research back into spotlight. This insight briefly summarizes the well-established cAMP signaling pathways in mammalian cells and describes the turbulent and controversial history of plant cAMP research highlighting the major progress and the unresolved points. We also briefly review the current paradigm of auxin signaling to provide a background for the discussion on the AC activity of TIR1/AFB auxin receptors and its potential role in transcriptional auxin signaling as well as impact of these discoveries on plant cAMP research in general.

Indexed as

ArabidopsisArabidopsis ProteinsF-Box ProteinsCyclic AMPGene Expression Regulation, PlantIndoleacetic AcidsPlant Growth RegulatorsReceptors, Cell SurfaceSecond Messenger SystemsArabidopsis ProteinsCyclic AMPF-Box ProteinsIndoleacetic AcidsPlant Growth RegulatorsReceptors, Cell Surfaceadenylate cyclaseauxin signalingcyclic adenosine monophosphate (cAMP)second messengertransport inhibitor response 1/auxin-signaling F-box proteins (TIR1/AFBs)

Identifiers

PMID37434303
PMCPMC10952583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.